Bürgenstock: CME’s Gill Says Interoperability Kills Innovation

27 Sep 2013

Interoperability of global clearing models is not only undesirable but could kill product innovation, said Phupinder Gill, ceo of CME Group, at the 34th Bürgenstock annual global derivatives markets conference in Geneva.

Interoperability of global clearing models is not only undesirable but could kill product innovation, said Phupinder Gill, ceo of CME Group, at the 34th Bürgenstock annual global derivatives markets conference in Geneva.

"Innovation is the lifeblood of a company such as CME group and to have interoperability kills that ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial